Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV1.7 sodium channels-Reference-Cited by-同舟云学术

Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV1.7 sodium channels

Author:

Cregg R¹²,Cox J J¹,Bennett D L H³,Wood J N¹,Werdehausen R¹⁴

Affiliation:

1. Molecular Nociception Group; Wolfson Institute for Biomedical Research; UCL; London UK

2. UCL Centre for Anaesthesia, Critical Care and Pain Medicine; London UK

3. The Nuffield Department of Clinical Neuroscience; University of Oxford; UK

4. Department of Anesthesiology, Medical faculty; Heinrich-Heine-University; Düsseldorf Germany

Funder

National Institute for Academic Anaesthesia

Research Councils UK

Publisher

Wiley

Subject

Pharmacology

Link

Reference37 articles.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucocutaneous Pain Syndromes;Rook's Textbook of Dermatology;2024-03-19

2. Painful Raynaud's mimics;Best Practice & Research Clinical Rheumatology;2024-03

4. Human pain channelopathies;Handbook of Clinical Neurology;2024